An increasing body of evidence indicates that elevated levels of uromodulin, whether in the urine or serum, are independently associated with a reduced risk of developing acute and chronic kidney disease, as well as the progression of kidney disease, cardiovascular disease, and mortality. Here, UMOD is linked to kidney disorder.